Announce Date | 04/30/2025 |
EPS Normalized Actual | $-0.18 (Beat by $0.44) |
EPS GAAP Actual | $-0.18 (Beat by $0.44) |
Revenue Actual | $1.07688B |
Revenue Surprise | Beat by $1076.88M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.80875 |
EPS GAAP Estimate | $1.80875 |
Revenue Estimate | $1.71000613B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 29.8 | 2.28 | 24.63464 | 39.91366 | 2 |
Dec 2027 | 22.545 | 3.01 | 18.63718 | 30.19643 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.0029 | -1.68572 | 1.07688B | -26.36% | -409.76M |
FQ4 2024 (Dec 2024) | 0.29 | 0.29 | 1.23171B | -91.29% | 1231.71M |
FQ3 2024 (Sep 2024) | -9.45 | -9.45 | 1.35469B | -70.56% | 1354.69M |
FQ2 2024 (Jun 2024) | -3.94 | -3.94 | 1.43039B | -65.7% | 1430.39M |
FQ1 2024 (Mar 2024) | -1.4 | -1.4 | 1.36074B | -89.62% | 1360.74M |
FQ4 2023 (Dec 2023) | -5.26 | -5.26 | 2.35617B | 100% | 2356.17M |
FQ3 2023 (Sep 2023) | 2.58 | 2.58 | 2.3106B | 9.47% | 2310.6M |
FQ2 2023 (Jun 2023) | 5.54 | 5.54 | 2.37019B | 37.58% | 2370.19M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.80875
Consensus Revenue Estimates
1.71000613B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.2583 | -- | 1.19897 | 1.34598 | 1 |
FQ2 2027 (Jun 2027) | 1.18572 | -- | 1.12982 | 1.26834 | 1 |
FQ1 2027 (Mar 2027) | 0.58603 | -- | 0.5584 | 0.62687 | 1 |
FQ4 2026 (Oct 2026) | 2.64677 | -- | 2.06179 | 3.47 | 5 |
FQ3 2026 (Jul 2026) | 2.29774 | -- | 1.7899 | 3.01241 | 5 |
FQ2 2026 (Jun 2026) | 2.04123 | -- | 1.56453 | 2.60593 | 4 |
FQ1 2026 (Mar 2026) | 1.66567 | 100.17 | 1.27939 | 2.20066 | 11 |
FQ4 2025 (Oct 2025) | 2.09296 | 86.14 | 1.63038 | 2.74394 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.74B | -- | 1.68B | 1.84B | 2 |
FQ2 2027 (Jun 2027) | 1.7B | -- | 1.64B | 1.79B | 2 |
FQ1 2027 (Mar 2027) | 1.51B | -- | 1.45B | 1.59B | 2 |
FQ4 2026 (Oct 2026) | 2.25B | -- | 1.87B | 2.79B | 8 |
FQ3 2026 (Jul 2026) | 2.07B | -- | 1.71B | 2.56B | 5 |
FQ2 2026 (Jun 2026) | 1.92B | -- | 1.57B | 2.33B | 4 |
FQ1 2026 (Mar 2026) | 1.72B | 37.35 | 1.41B | 2.14B | 5 |
FQ4 2025 (Oct 2025) | 1.79B | 31.03 | 1.48B | 2.21B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.68282 | -0.0029 | -1.68572 | 58128.28% |
FQ4 2024 (Dec 2024) | 0.29 | 0.29 | 100% | |
FQ3 2024 (Sep 2024) | -9.45 | -9.45 | 100% | |
FQ2 2024 (Jun 2024) | -3.94 | -3.94 | 100% | |
FQ1 2024 (Mar 2024) | -1.4 | -1.4 | 100% | |
FQ4 2023 (Dec 2023) | -5.26 | -5.26 | 100% | |
FQ3 2023 (Sep 2023) | 2.58 | 2.58 | 100% | |
FQ2 2023 (Jun 2023) | 5.54 | 5.54 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.49B | $1.08B | $-409.76M | -38.05% |
FQ4 2024 (Dec 2024) | $0B | $1.23B | $1231.71M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.35B | $1354.69M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.43B | $1430.39M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.36B | $1360.74M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.36B | $2356.17M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.31B | $2310.6M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.37B | $2370.19M | 100% |